New Roche drug helps melanoma patients | March 16, 2012 | Pleasanton Weekly | |

Pleasanton Weekly

- March 16, 2012

New Roche drug helps melanoma patients

Twice-a-day pill shown to improve patient survival

A metastatic melanoma drug developed by Roche Molecular Diagnostics of Pleasanton in concert with Berkeley-based Plexxikon Inc. has been approved by European regulators for adult patients with the most aggressive form of skin cancer.

This story contains 169 words.

If you are a paid subscriber, check to make sure you have logged in. Otherwise our system cannot recognize you as having full free access to our site.

If you are a paid print subscriber and haven't yet set up an online account, click here to get your online account activated.


There are no comments yet for this post